A stronger approach to weakness in the intensive care unit
© BioMed Central Ltd 2004
Published: 1 October 2004
ICU-acquired limb and respiratory muscle weakness is a common, serious ICU syndrome, increasing in frequency with prolonged ICU stay and sepsis. A systematic approach facilitates precise localization of the problem within central or peripheral nervous system. Most cases relate to critical illness polyneuropathy or myopathy or a combination of both (critical illness neuromyopathy). Within the latter entity, the relative contribution of neuropathy versus myopathy varies considerably among affected patients. Muscle enzyme testing, electromyography-nerve conduction and muscle biopsy are valuable investigative tests. Nerve biopsy is less commonly needed, but is useful when vascultis is suspected.
KeywordsICU myopathy neuropathy ventilator weakness
The syndrome of severe, acute, intensive care unit (ICU)-acquired neuromuscular weakness poses a common and serious diagnostic, prognostic, and therefore management issue. It goes by various names, some of which presuppose a mechanism: acute necrotizing myopathy of intensive care, acute quadriplegic myopathy, critical care myopathy, critical illness myopathy (CIM), critical illness neuromuscular disease, critical illness neuromyopathy, critical illness polyneuromyopathy, critical illness polyneuropathy (CIP), ICU-acquired paresis, quadriplegic and areflexic ICU illness, rapidly evolving myopathy with myosin-deficient fibres and thick filament myopathy [1–6]. The problem affects at least 1.7% of children in paediatric ICUs, more than half of adult patients admitted to general ICUs for more than 1 week and more than 70% of those with sepsis and multiorgan failure [7–9]. Neuromuscular weakness typically becomes apparent when an attempt is made to wean the patient from the ventilator, although there are earlier clues, which include grimacing without movement with noxious stimuli before recovery of consciousness, relative lack of movement after regaining consciousness, and (not inevitably) loss of deep tendon reflexes that had been present earlier .
The last step, differentiating the most common causes of ICU-acquired generalized weakness (myopathy, neuropathy, or a combination of the two), is practical because their prognoses differ considerably. Some cases of myopathy appear to be merely 'membranopathies', with normal histology and rapid recovery. Presumably, the muscle membrane becomes dysfunctional, inexcitable and leaky, allowing myoglobin to leave the muscle. Some cases behave like disuse atrophy with selective type-2 fibre loss. Others, especially in those treated with corticosteroids and neuromuscular blocking agents, exhibit a relative loss of thick myosin filaments. Many cases show variable panfascicular necrosis, which can sometimes be widespread and severe. In general, the prognosis for recovery from myopathies is favourable, with most patients recovering fully within 1–3 months . Patients with widespread muscle necrosis may recover incompletely, however. Severe CIP patients recover slowly because the axons regenerate at 1 mm/day. This takes many months and recovery is often incomplete, leaving patients with significant weakness, sensory loss, and absent reflexes distally in the lower limbs and variably more proximally. Patients with CIP who fail to show significant recovery by 4 weeks are often disabled with diminished quality of life . Evidence of polyneuropathy is apparent after 5 years in over 90% of CIP patients . The mildest residua may include reduced stamina for walking. Some older patients may fail to survive or wean from the ventilator because their recovery is so protracted and other complications ensue.
Electromyography is helpful in differentiating CIP from CIM but it has limitations . Reduced or absent sensory nerve action potentials favours a neuropathy, but sensory potentials may be difficult to record if there is considerable oedema or a pre-existing polyneuropathy (e.g. from diabetes mellitus) may have clouded the issue. Direct muscle stimulation (not commonly done) may reveal no or absent response in CIM but normal responses in CIP . Unfortunately, needle electrode studies of muscle can show similar features in CIP and CIM; both may exhibit spontaneous activity (fibrillations and positive sharp waves). Often CIP and CIM coexist and their relative contributions to the weakness may vary considerably when this occurs. Elevated serum creatine kinase may help to identify CIM, but the peak may be missed in the membranopathy/necrotizing varieties or creatine kinase may not be significantly elevated in cases with loss of myosin filaments. To determine the relative contributions of nerve versus muscle disease in explaining weakness, muscle or both nerve and muscle biopsies have been utilized and recommended , most recently in this issue by Kerbaul and colleagues . In most cases muscle biopsy will address the relative contribution of myopathy to the picture because the neuropathy can be adequately assessed electrophysiologically. Percutaneous muscle biopsy, although providing limited tissue, has a number of advantages over operative biopsies: greater spatial sampling, minimal bleeding, negligible infection rate (we have had none in over 1000 biopsies), portability (done at the bedside), no general anaesthetic, speed of performance and ease of arrangement. Nerve and muscle biopsy is seldom necessary in the ICU, unless a vasculitis is suspected. An open muscle biopsy may also be necessary if the needle biopsies are inadequate.
Being aware of the incidence and signs of ICU-acquired weakness with ventilatory failure and having an approach to such disorders will prove valuable in management. Some conditions are treatable. Further insights into the mechanisms of CIP and CIM may provide some preventive strategies that will ameliorate their severity, shorten the duration of ICU stays and improve long-term outcomes.
critical illness myopathy
critical illness polyneuropathy
intensive care unit.
- De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, et al.: Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002, 288: 2859-2867. 10.1001/jama.288.22.2859View ArticlePubMed
- Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA: Critical illness polyneuropathy: a complication of sepsis and multi-organ failure. Brain 1987, 110: 819-842.View ArticlePubMed
- Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, De Maria G, Antonini L, Rizzuto N, Candiani A: Critical illness myopathy and neuropathy. Lancet 1996, 347: 1579-1582. 10.1016/S0140-6736(96)91074-0View ArticlePubMed
- Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ: Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996, 46: 731-736.View ArticlePubMed
- Hund E: Myopathy in critically ill patients. Crit Care Med 1999, 27: 2544-2547. 10.1097/00003246-199911000-00036View ArticlePubMed
- Lacomas D, Zochodne DW, Bird SJ: Critical illness myopathy: what's in a name? Muscle Nerve 2000, 23: 1785-1788. 10.1002/1097-4598(200012)23:12<1785::AID-MUS1>3.0.CO;2-JView Article
- Banwell BL, Mildner RJ, Hassall AC, Becker LE, Vajsar J, Shemie SD: Muscle weakness in critically ill children. Neurology 2003, 61: 1779-1782.View ArticlePubMed
- Leijten FS, Harinck-de Weerd JE, Poortvliet DC, de Weerd AW: The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995, 274: 1221-1225. 10.1001/jama.274.15.1221View ArticlePubMed
- Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young GB, Sibbald WJ: Peripheral nerve function in sepsis and multiple organ failure. Chest 1991, 99: 176-184.View ArticlePubMed
- Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ: Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984, 47: 1223-1231.PubMed CentralView ArticlePubMed
- Bednarik J, Lukas Z, Vondracek P: Critical illness polyneuropathy: the electrophysiological components of a complex entity. Intensive Care Med 2003, 29: 1505-1514. 10.1007/s00134-003-1858-0View ArticlePubMed
- Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, Hinds CJ: Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003, 31: 1012-1016. 10.1097/01.CCM.0000053651.38421.D9View ArticlePubMed
- Bolton CF: Electrophysiologic studies in critically ill patients. Muscle Nerve 1987, 10: 129-135.View ArticlePubMed
- Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW: Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997, 20: 665-673. 10.1002/(SICI)1097-4598(199706)20:6<665::AID-MUS2>3.3.CO;2-3View ArticlePubMed
- Kerbaul F, Brousse M, Collart F, Pellissier J-F, Planche D, Fernan-dez C, Gouin F, Guidon C: Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit Care 2004, 8: R358-R366. 10.1186/cc2925PubMed CentralView ArticlePubMed
- Bolton CF, Young GB: The neurological consultation and neurological syndromes in the intensive care unit. Balliere's Clin Neurol 1996,5(3):447-475.